| Benjamin Lashar Hoch, MD | |
|
1212 Pleasant, Suite #ll3, Des Moines, IA 50309-1414 | |
| (515) 241-8861 | |
| (515) 241-8855 |
| Full Name | Benjamin Lashar Hoch |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 25 Years |
| Location | 1212 Pleasant, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700884665 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Unitypoint Health - Des Moines Iowa Methodist Medi | Des moines, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regional Laboratory Consultants Pc | 6901709062 | 11 |
News Archive
While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12-week regiment, investing in these new therapies could generate savings estimated at more than $3.2 billion annually in the U.S. and five European countries, according to a new study (abstract 228) released today at Digestive Disease Week® (DDW) 2015.
Using a specially selected library of different hepatitis C viruses, a team of researchers led by Johns Hopkins scientists has identified tiny differences in the pathogens' outer shell proteins that underpin their resistance to antibodies.
e-Therapeutics plc today provides an update on the clinical trials of its cancer drug ETS2101. Two phase I studies, one in patients with primary or secondary brain cancer and the other in patients with various solid tumours, remain on track to report final data in Q4 2013 and Q1 2014, respectively. Interim data from the trials are expected in H1 2013.
The cellular cause of birth defects like cleft palates, missing teeth and problems with fingers and toes has been a tricky puzzle for scientists. Now Professor Emily Bates and her biochemistry students at Brigham Young University have placed an important piece of the developmental puzzle. They studied an ion channel that regulates the electrical charge of a cell. In a new study published by the journal Development, they show that blocking this channel disrupts the work of a protein that is supposed to carry marching orders to the nucleus.
The President's Emergency Plan for AIDS Relief is "dead on track" to meet its goal of providing antiretroviral drugs to two million people when it's five-year authorization expires in 2008, Ambassador Mark Dybul, who serves as the U.S. global AIDS coordinator and administers PEPFAR, said Thursday in an interview during a visit to San Francisco, the San Francisco Chronicle reports.
› Verified 8 days ago
| Entity Name | Regional Laboratory Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891805958 PECOS PAC ID: 6901709062 Enrollment ID: O20040128000391 |
News Archive
While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12-week regiment, investing in these new therapies could generate savings estimated at more than $3.2 billion annually in the U.S. and five European countries, according to a new study (abstract 228) released today at Digestive Disease Week® (DDW) 2015.
Using a specially selected library of different hepatitis C viruses, a team of researchers led by Johns Hopkins scientists has identified tiny differences in the pathogens' outer shell proteins that underpin their resistance to antibodies.
e-Therapeutics plc today provides an update on the clinical trials of its cancer drug ETS2101. Two phase I studies, one in patients with primary or secondary brain cancer and the other in patients with various solid tumours, remain on track to report final data in Q4 2013 and Q1 2014, respectively. Interim data from the trials are expected in H1 2013.
The cellular cause of birth defects like cleft palates, missing teeth and problems with fingers and toes has been a tricky puzzle for scientists. Now Professor Emily Bates and her biochemistry students at Brigham Young University have placed an important piece of the developmental puzzle. They studied an ion channel that regulates the electrical charge of a cell. In a new study published by the journal Development, they show that blocking this channel disrupts the work of a protein that is supposed to carry marching orders to the nucleus.
The President's Emergency Plan for AIDS Relief is "dead on track" to meet its goal of providing antiretroviral drugs to two million people when it's five-year authorization expires in 2008, Ambassador Mark Dybul, who serves as the U.S. global AIDS coordinator and administers PEPFAR, said Thursday in an interview during a visit to San Francisco, the San Francisco Chronicle reports.
› Verified 8 days ago
| Entity Name | Broadlawns Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467447508 PECOS PAC ID: 3678466166 Enrollment ID: O20040206000913 |
News Archive
While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12-week regiment, investing in these new therapies could generate savings estimated at more than $3.2 billion annually in the U.S. and five European countries, according to a new study (abstract 228) released today at Digestive Disease Week® (DDW) 2015.
Using a specially selected library of different hepatitis C viruses, a team of researchers led by Johns Hopkins scientists has identified tiny differences in the pathogens' outer shell proteins that underpin their resistance to antibodies.
e-Therapeutics plc today provides an update on the clinical trials of its cancer drug ETS2101. Two phase I studies, one in patients with primary or secondary brain cancer and the other in patients with various solid tumours, remain on track to report final data in Q4 2013 and Q1 2014, respectively. Interim data from the trials are expected in H1 2013.
The cellular cause of birth defects like cleft palates, missing teeth and problems with fingers and toes has been a tricky puzzle for scientists. Now Professor Emily Bates and her biochemistry students at Brigham Young University have placed an important piece of the developmental puzzle. They studied an ion channel that regulates the electrical charge of a cell. In a new study published by the journal Development, they show that blocking this channel disrupts the work of a protein that is supposed to carry marching orders to the nucleus.
The President's Emergency Plan for AIDS Relief is "dead on track" to meet its goal of providing antiretroviral drugs to two million people when it's five-year authorization expires in 2008, Ambassador Mark Dybul, who serves as the U.S. global AIDS coordinator and administers PEPFAR, said Thursday in an interview during a visit to San Francisco, the San Francisco Chronicle reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin Lashar Hoch, MD 1212 Pleasant, Suite #ll3, Des Moines, IA 50309-1414 Ph: (515) 241-8861 | Benjamin Lashar Hoch, MD 1212 Pleasant, Suite #ll3, Des Moines, IA 50309-1414 Ph: (515) 241-8861 |
News Archive
While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12-week regiment, investing in these new therapies could generate savings estimated at more than $3.2 billion annually in the U.S. and five European countries, according to a new study (abstract 228) released today at Digestive Disease Week® (DDW) 2015.
Using a specially selected library of different hepatitis C viruses, a team of researchers led by Johns Hopkins scientists has identified tiny differences in the pathogens' outer shell proteins that underpin their resistance to antibodies.
e-Therapeutics plc today provides an update on the clinical trials of its cancer drug ETS2101. Two phase I studies, one in patients with primary or secondary brain cancer and the other in patients with various solid tumours, remain on track to report final data in Q4 2013 and Q1 2014, respectively. Interim data from the trials are expected in H1 2013.
The cellular cause of birth defects like cleft palates, missing teeth and problems with fingers and toes has been a tricky puzzle for scientists. Now Professor Emily Bates and her biochemistry students at Brigham Young University have placed an important piece of the developmental puzzle. They studied an ion channel that regulates the electrical charge of a cell. In a new study published by the journal Development, they show that blocking this channel disrupts the work of a protein that is supposed to carry marching orders to the nucleus.
The President's Emergency Plan for AIDS Relief is "dead on track" to meet its goal of providing antiretroviral drugs to two million people when it's five-year authorization expires in 2008, Ambassador Mark Dybul, who serves as the U.S. global AIDS coordinator and administers PEPFAR, said Thursday in an interview during a visit to San Francisco, the San Francisco Chronicle reports.
› Verified 8 days ago
Ramona Ann Thompson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-8638 | |
Dr. Carolyn Su-ying Pease, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Avenue, Mercy Medical Center, Des Moines, IA 50314 Phone: 515-643-8533 Fax: 515-643-8911 | |
Dr. Lorie A. Montag, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1212 Pleasant, Suite #ll3, Des Moines, IA 50309 Phone: 515-241-8861 Fax: 515-241-8855 | |
Timothy Floyd Drevyanko, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1212 Pleasant, #ll3, Des Moines, IA 50309 Phone: 515-241-8866 Fax: 515-241-8855 | |
Jacob Edward Sramek, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1212 Pleasant St, Suite Ll3, Des Moines, IA 50309 Phone: 515-241-8866 | |
Edward Fredric Loeb, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1212 Pleasant, #ll3, Des Moines, IA 50309 Phone: 515-241-8866 Fax: 515-241-8855 | |
Richard Kent Scupham, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1212 Pleasant, #ll3, Des Moines, IA 50309 Phone: 515-241-8866 Fax: 515-241-8855 |